ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Khan S, Chari ST. Pancreatology 2025 Nov 12:S1424-3903(25)00680-5. doi: 10.1016/j.pan.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khan S, Chari ST. ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology 2025 Nov 12:S1424-3903(25)00680-5. doi: 10.1016/j.pan.2025.
PMID: 41260940